Your browser doesn't support javascript.
loading
FDA approved fused-pyrimidines as potential PI3K inhibitors: a computational repurposing approach.
Vishwakarma, Pinky; Siddiqui, Noor Fatima; Thakur, Shikha; Jadhav, Hemant.
Affiliation
  • Vishwakarma P; Pharmaceutical Chemistry Laboratory, Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Pilani, Rajasthan, India.
  • Siddiqui NF; Pharmaceutical Chemistry Laboratory, Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Pilani, Rajasthan, India.
  • Thakur S; Pharmaceutical Chemistry Laboratory, Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Pilani, Rajasthan, India.
  • Jadhav H; Pharmaceutical Chemistry Laboratory, Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Pilani, Rajasthan, India.
J Biomol Struct Dyn ; : 1-18, 2023 Nov 01.
Article in En | MEDLINE | ID: mdl-37909480
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Biomol Struct Dyn Year: 2023 Type: Article Affiliation country: India
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Biomol Struct Dyn Year: 2023 Type: Article Affiliation country: India